Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 999-1007
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.999
Carcinoembryonic antigen in the diagnosis, treatment, and follow-up of focal liver lesions
Osman Nuri Dilek, Dilara İrem Arslan Kahraman, Gökhan Kahraman
Osman Nuri Dilek, Department of Surgery, İzmir Katip Celebi University, School of Medicine, İzmir 35150, Turkey
Dilara İrem Arslan Kahraman, Department of Patology, Merzifon KMP State Hospital, Amasya 5300, Turkey
Gökhan Kahraman, Department of Radiology, Suluova State Hospital, Amasya 5500, Turkey
Author contributions: Dilek ON designed the overall concept and outline of the manuscript; Arslan Kahraman Dİ and Kahraman G contributed the contemporary data related to pathology and radiology to the discussion; Kahraman G and Dilek ON also contributed to the writing, editing, and review of the literature.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Osman Nuri Dilek, FACS, Professor, Department of Surgery, İzmir Katip Celebi University, School of Medicine, Basın Sitesi, İzmir 35150, Turkey. osmannuridilek@gmail.com
Received: January 7, 2024
Peer-review started: January 7, 2024
First decision: January 30, 2024
Revised: February 2, 2024
Accepted: March 13, 2024
Article in press: March 13, 2024
Published online: April 27, 2024
Core Tip

Core Tip: Carcinoembryonic antigen (CEA) is not normally produced in significant quantities after birth but is mainly elevated in colorectal cancer and some other pathologies. CEA is widely used not only for diagnostic tumor markers but also importantly for the management of some gastrointestinal tumors. In this study, the relationship of CEA with clinical, radiological, and histopathological evaluations in the diagnosis and treatment of focal liver lesions detected in the liver was evaluated with a holistic approach.